Cenobamate sNDA Seeks FDA Approval for Generalized Seizures

Author profile image Aggregator
0 comments
A new FDA filing seeks to expand cenobamate's epilepsy indication to primary generalized tonic-clonic seizures, based on positive phase 3 trial data.

Source: NeurologyLive Published 16 Nov 2026 Imported 16 Nov 2026 Relevancy: Not reviewed

Read the article